Galina A. Aleshkina
Research Subjects
Galina A. Aleshkina has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Leonid M. Bardenshteyn
Russian University of Medicine
3 shared publications - Margarita E. Pugacheva
Evdokimov Moscow State University of Medicine and Dentistry
2 shared publications - Nicolay I. Beglyankin
Evdokimov Moscow State University of Medicine and Dentistry
2 shared publications Беглянкин Николай Игоревич
Московский государственный медико-стоматологический университет им. А.И. Евдокимова
2 shared publications- Aleksandr Tsimbalistov
Belgorod State National Research University
1 shared publication - Alexey Yurievich Drobyshev
Federal State Budgetary Educational Institution of Higher Education «Russian University of Medicine» of the Ministry of Health of Russia
1 shared publication
Latest Publications
- 23 November 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (5) , 333-343
Comparative study of the effect of vortioxetine on sexual function in outpatient patients with non-psychotic depression
BACKGROUND: The negative effect of sexual dysfunction on the quality of life is often underestimated, although it is one of the determinants of antidepressant tolerance. According to the results of international studies, the prevalence of sexual dysfunction in patients with depression treated with selective serotonin reuptake inhibitors or selective serotonin and norepinephrine reuptake inhibitors is 2765% in women and 2657% in men. Treatment with fewer adverse sexual effects should be considered a potential first-line option in patients with psychiatric condition interested in maintaining a sexual life. AIM: To study the effects of vortioxetine and citalopram on the sexual function of outpatients with non-psychotic depression. MATERIALS AND METHODS: The study was conducted based on the Center for Psychosomatic Medicine and Psychotherapy. We examined 134 patients (mean age, 35.87.6 years) who underwent outpatient treatment by a psychiatrist. Among them, 71 patients received vortioxetine, 45 patients had depressive states of endogenous origin (15 patients with affective disorders and 30 patients with schizotypal disorder), and 26 patients had adjustment disorder. Citalopram was administered in 63 patients: 39 with depressive conditions within endogenous diseases (18 with affective disorders and 21 with schizotypal disorder) and 24 patients with adjustment disorder. The study lasted for 6 weeks, after which sexual function was assessed. RESULTS: In the groups taking vortioxetine and citalopram, significant differences were found in the incidence of sexual dysfunction: the use of vortioxetine compared with citalopram allowed patients to maintain libido and orgasmic function and, in some cases, helped restore the sexual sphere. CONCLUSION: The data obtained showed that vortioxetine was statistically significantly more favorable in relation to sexual function.
- 23 November 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (5) , 333-343
Comparative study of the effect of vortioxetine on sexual function in outpatient patients with non-psychotic depression
BACKGROUND: The negative effect of sexual dysfunction on the quality of life is often underestimated, although it is one of the determinants of antidepressant tolerance. According to the results of international studies, the prevalence of sexual dysfunction in patients with depression treated with selective serotonin reuptake inhibitors or selective serotonin and norepinephrine reuptake inhibitors is 2765% in women and 2657% in men. Treatment with fewer adverse sexual effects should be considered a potential first-line option in patients with psychiatric condition interested in maintaining a sexual life. AIM: To study the effects of vortioxetine and citalopram on the sexual function of outpatients with non-psychotic depression. MATERIALS AND METHODS: The study was conducted based on the Center for Psychosomatic Medicine and Psychotherapy. We examined 134 patients (mean age, 35.87.6 years) who underwent outpatient treatment by a psychiatrist. Among them, 71 patients received vortioxetine, 45 patients had depressive states of endogenous origin (15 patients with affective disorders and 30 patients with schizotypal disorder), and 26 patients had adjustment disorder. Citalopram was administered in 63 patients: 39 with depressive conditions within endogenous diseases (18 with affective disorders and 21 with schizotypal disorder) and 24 patients with adjustment disorder. The study lasted for 6 weeks, after which sexual function was assessed. RESULTS: In the groups taking vortioxetine and citalopram, significant differences were found in the incidence of sexual dysfunction: the use of vortioxetine compared with citalopram allowed patients to maintain libido and orgasmic function and, in some cases, helped restore the sexual sphere. CONCLUSION: The data obtained showed that vortioxetine was statistically significantly more favorable in relation to sexual function.
- 29 August 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (3) , 181-192
Personalized approach to early diagnosis of acute schizophrenia: an observational comparative study
BACKGROUND: An acute schizophrenic episode often meets the diagnostic criteria for the ICD-10 category acute and transient psychotic disorders (ATPD, F23), which includes clinically similar conditions of diverse etiologies. The presence of schizophrenic negative symptoms in ATPD signifies their nosological affiliation and determines the therapeutic tactics. Early recognition of the schizophrenic etiology in the first episode of psychosis may contribute to the development of a personalized approach for the management of patients with acute psychotic disorders. AIM: To evaluate the relationship between the developmental characteristics of psychosis and identify the negative symptoms after its reduction in patients with ATPD with the symptoms of schizophrenia. MATERIALS AND METHODS: This observational single-center selective comparative study was conducted during 20182020. The clinical-psychopathological method was applied to examine patients hospitalized in a psychiatric hospital with ATPD presenting with the symptoms of schizophrenia (F23.1). In order to objectify the results of the study, the positive and negative syndrome scale was used. RESULTS: The study involved 60 patients (50 men, 10 women) aged 1846 years (mean age: 21.46.0 years). Depending on the presence of negative symptoms after the psychosis reduction at 4 weeks of therapy, the study sample was divided into two groups: 1) the group with negative symptoms (NS+; n=41); 2) the group without any negative symptoms (NS; n=19). Individuals presenting with negative symptoms were distinguished from those without it based on the more frequent presence of prodromal disorders, subpsychotic, and, particularly, mild negative disorders at the prodromal stage, prolonged development, and long-drawn course of psychosis. The likelihood of negative symptoms detection after the reduction of psychosis was associated with a family history of schizophrenia and other psychiatric disorders, low premorbid social adjustment, prodromal symptoms, and impaired functioning, as well as with a longer duration of psychotic symptoms and its slow development. CONCLUSION: The likelihood of negative symptoms after the reduction of ATPD with symptoms of schizophrenia was associated with hereditary and premorbid characteristics of patients, prodromal psychopathological and functional abnormalities, as well as the clinical and dynamic characteristics of psychosis. The data obtained from this study may contribute to the early recognition of schizophrenia-spectrum disorders and to the development of a personalized approach for the management of patients with ATPD.
- 29 August 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (3) , 181-192
Personalized approach to early diagnosis of acute schizophrenia: an observational comparative study
BACKGROUND: An acute schizophrenic episode often meets the diagnostic criteria for the ICD-10 category acute and transient psychotic disorders (ATPD, F23), which includes clinically similar conditions of diverse etiologies. The presence of schizophrenic negative symptoms in ATPD signifies their nosological affiliation and determines the therapeutic tactics. Early recognition of the schizophrenic etiology in the first episode of psychosis may contribute to the development of a personalized approach for the management of patients with acute psychotic disorders. AIM: To evaluate the relationship between the developmental characteristics of psychosis and identify the negative symptoms after its reduction in patients with ATPD with the symptoms of schizophrenia. MATERIALS AND METHODS: This observational single-center selective comparative study was conducted during 20182020. The clinical-psychopathological method was applied to examine patients hospitalized in a psychiatric hospital with ATPD presenting with the symptoms of schizophrenia (F23.1). In order to objectify the results of the study, the positive and negative syndrome scale was used. RESULTS: The study involved 60 patients (50 men, 10 women) aged 1846 years (mean age: 21.46.0 years). Depending on the presence of negative symptoms after the psychosis reduction at 4 weeks of therapy, the study sample was divided into two groups: 1) the group with negative symptoms (NS+; n=41); 2) the group without any negative symptoms (NS; n=19). Individuals presenting with negative symptoms were distinguished from those without it based on the more frequent presence of prodromal disorders, subpsychotic, and, particularly, mild negative disorders at the prodromal stage, prolonged development, and long-drawn course of psychosis. The likelihood of negative symptoms detection after the reduction of psychosis was associated with a family history of schizophrenia and other psychiatric disorders, low premorbid social adjustment, prodromal symptoms, and impaired functioning, as well as with a longer duration of psychotic symptoms and its slow development. CONCLUSION: The likelihood of negative symptoms after the reduction of ATPD with symptoms of schizophrenia was associated with hereditary and premorbid characteristics of patients, prodromal psychopathological and functional abnormalities, as well as the clinical and dynamic characteristics of psychosis. The data obtained from this study may contribute to the early recognition of schizophrenia-spectrum disorders and to the development of a personalized approach for the management of patients with ATPD.
- 29 August 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (3) , 223-236
Dysthymia: nosology, systematics, clinical and social significance: а literature review
The issues of nosology, systematics, and clinical and social significance of dysthymia are a serious problem of modern medicine. Dysthymia significantly contributes to the structure of depressive disorders. Although its symptoms are mild, the disease is associated with high risks of disability, concomitant health problems, and mortality. There is no established system of classifying and diagnosing chronic mild depression. This review presents epidemiological data, historical review, and nosology, along with the assessment of persistent depressive disorder. Full-text articles and fragments of monographs selected by keywords in the databases Scopus, Web of Science, MEDLINE, RSCI, Psychiatrist, ScienceDirect were used for research.
- 29 August 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (3) , 223-236
Dysthymia: nosology, systematics, clinical and social significance: а literature review
The issues of nosology, systematics, and clinical and social significance of dysthymia are a serious problem of modern medicine. Dysthymia significantly contributes to the structure of depressive disorders. Although its symptoms are mild, the disease is associated with high risks of disability, concomitant health problems, and mortality. There is no established system of classifying and diagnosing chronic mild depression. This review presents epidemiological data, historical review, and nosology, along with the assessment of persistent depressive disorder. Full-text articles and fragments of monographs selected by keywords in the databases Scopus, Web of Science, MEDLINE, RSCI, Psychiatrist, ScienceDirect were used for research.
- 15 July 2021
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 27 (4) , 395-406
Mental disorders associated with the novel coronavirus infection coronavirus disease-2019
This study presents data from recent publications on the occurrence of mental disorders during the coronavirus disease-2019 (COVID-19) pandemic and the specifics of providing mental health care under social isolation conditions. The issues of negative psychopathological outcome prevention in persons with high-risk mental disorders are considered, as well as the problems of organizing psychiatric care provision during the pandemic, including the possibility of remote counseling and follow-up. The questions of the pathogenesis of psychopathological symptoms in coronavirus infection are discussed. Particular attention is paid to the adverse effects of COVID-19 therapy, psychotropic drugs interactions, and drug treatment for patients with coronavirus infection. The research results and opinions of Russian and international specialists in the field of mental health that are presented in this review are relevant for medical practitioners working in the pandemic.
- 15 July 2021
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 27 (4) , 395-406
Mental disorders associated with the novel coronavirus infection coronavirus disease-2019
This study presents data from recent publications on the occurrence of mental disorders during the coronavirus disease-2019 (COVID-19) pandemic and the specifics of providing mental health care under social isolation conditions. The issues of negative psychopathological outcome prevention in persons with high-risk mental disorders are considered, as well as the problems of organizing psychiatric care provision during the pandemic, including the possibility of remote counseling and follow-up. The questions of the pathogenesis of psychopathological symptoms in coronavirus infection are discussed. Particular attention is paid to the adverse effects of COVID-19 therapy, psychotropic drugs interactions, and drug treatment for patients with coronavirus infection. The research results and opinions of Russian and international specialists in the field of mental health that are presented in this review are relevant for medical practitioners working in the pandemic.
- 1 July 2020
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 27-33
Acute and Chronic Depressive Disorders in Head and Neck Cancer Patients
The review focuses on depressive disorders in cancer patients. The article summarizes the findings of domestic and foreign studies on depression prevalence, clinical symptoms and treatment in head and neck cancer patients. Early detection of affective disorder and timely administration of antipsychotic drug treatment is shown to be important for this patient category.
- 1 July 2020
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 27-33
Acute and Chronic Depressive Disorders in Head and Neck Cancer Patients
The review focuses on depressive disorders in cancer patients. The article summarizes the findings of domestic and foreign studies on depression prevalence, clinical symptoms and treatment in head and neck cancer patients. Early detection of affective disorder and timely administration of antipsychotic drug treatment is shown to be important for this patient category.
- 1 January 2013
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 28 (S1)
620 – Acute and Transient Psychotic Disorders: Comparison
Objective: To investigate clinical dynamics of acute and transient psychotic disorders during antipsychotic therapy.Methods: 35 primary inpatients of psychiatric hospital with acute and transient psychotic disorders (ICD-10, F 23) were observed for 6 months. Group 1 - 17 participants (26,7±7,1 years) with acute psychosis without schizophrenic symptoms (F 23.0). Group 2 - 18 inpatients (26,0±5,7 years) with acute psychosis including schizophrenic symptoms (F 23.1). All patients received haloperidol injections with subsequent switch to olanzapine or risperidone per os. Psychopathological dynamics was estimated on PANSS [Kay S.R. et al., 1987].Results: For the first group, the initial total PANSS score was lower (88,1±10,8) than for group 2 (123,3±7,7; p≤0,01). Duration of psychoses didn’t exceed 30 days in the first group. Longer psychotic episodes were typical to the 2nd group: ratio of the episodes lasting 6-30 days an 31-60 days was 50 to 50%. Negative symptoms, such as autism, passivity were revealed in all patients of group 2. The psychotic recurrence within 6 months after the first psychotic episode reduction occurred in 16%. Negative symptoms level estimated on PANSS in these patients was higher (26,7±4,2) than in whole group (23,7±5,6) [p≥0,05].Conclusions: The disorders diagnosed as F 23.0 and F 23.1 (ICD-10) differed in several patterns. Group 2 was characterized by stronger severity of psychotic symptoms; group 2 patients showed resistance to antipsychotic therapy. Moreover, the tendency to psychosis relapse was noticeable in cases with more strongly expressed negative symptoms after the first psychotic episode.
- 1 January 2013
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 28 (S1)
620 – Acute and Transient Psychotic Disorders: Comparison
Objective: To investigate clinical dynamics of acute and transient psychotic disorders during antipsychotic therapy.Methods: 35 primary inpatients of psychiatric hospital with acute and transient psychotic disorders (ICD-10, F 23) were observed for 6 months. Group 1 - 17 participants (26,7±7,1 years) with acute psychosis without schizophrenic symptoms (F 23.0). Group 2 - 18 inpatients (26,0±5,7 years) with acute psychosis including schizophrenic symptoms (F 23.1). All patients received haloperidol injections with subsequent switch to olanzapine or risperidone per os. Psychopathological dynamics was estimated on PANSS [Kay S.R. et al., 1987].Results: For the first group, the initial total PANSS score was lower (88,1±10,8) than for group 2 (123,3±7,7; p≤0,01). Duration of psychoses didn’t exceed 30 days in the first group. Longer psychotic episodes were typical to the 2nd group: ratio of the episodes lasting 6-30 days an 31-60 days was 50 to 50%. Negative symptoms, such as autism, passivity were revealed in all patients of group 2. The psychotic recurrence within 6 months after the first psychotic episode reduction occurred in 16%. Negative symptoms level estimated on PANSS in these patients was higher (26,7±4,2) than in whole group (23,7±5,6) [p≥0,05].Conclusions: The disorders diagnosed as F 23.0 and F 23.1 (ICD-10) differed in several patterns. Group 2 was characterized by stronger severity of psychotic symptoms; group 2 patients showed resistance to antipsychotic therapy. Moreover, the tendency to psychosis relapse was noticeable in cases with more strongly expressed negative symptoms after the first psychotic episode.